Close Window

Digital Look Email A Friend

Indivior to buy US overdose treatment firm Opiant for $145m

Published by Frank Prenesti on 14th November 2022

(Sharecast News) - UK-based drug company Indivior said it would pay $145m for Opiant Pharmaceuticals which produces treatments to overcome opioid addiction.

URL: http://www.digitallook.com/dl/news/story/33105199/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.